• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles 2018
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles 2018
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Therapeutic potential of bcl-xl/mcl-1 synthetic inhibitor jy-1-106 and retinoids for human triple-negative breast cancer treatment

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Perri, M.
    Yap, J.L.
    Fletcher, S.
    Date
    2018
    Journal
    Oncology Letters
    Publisher
    Spandidos Publications
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://dx.doi.org/10.3892/ol.2018.8258
    Abstract
    Overexpression of anti-apoptotic proteins belonging to the B cell lymphoma (Bcl)-2 family is observed in numerous cancer types and has been postulated to promote cancer cell survival and chemotherapy resistance. Bcl-extra large (xL)/myeloid cell leukemia sequence (Mcl)-1 was demonstrated to be expressed at relatively high levels in clinically aggressive basal-like cancers and inhibiting Bcl-xL overexpression could potentially provoke cell death. A molecule able to target Bcl-xL/Mcl-1, JY-1-106, is herein under investigation. It is also known that vitamin A-derived compounds exhibit antitumor activity in a variety of in vitro experimental models, promoting their effects via nuclear receptor isoforms including retinoic acid receptors (RARs). Pre-clinical observation highlighted that triple negative (estrogen receptor/progesterone receptor/human epidermal growth factor receptor)-breast cancer cells displayed resistance to retinoids due to the RARγ high expression profile. The present study used the triple-negative human breast cancer cell line, MDA-MB-231, to analyze the effects of the Bcl-xL/Mcl-1 synthetic inhibitor, JY-1-106, alone or in combination with retinoids on cell viability. The results revealed a synergistic effect in reducing cell viability primarily by using JY-1-106 with the selective RAR? antagonist SR11253, which induces massive autophagy and necrosis. Furthermore, the results highlighted that JY-1-106 alone is able to positively influence the gene expression profile of p53 and RARγ , providing a therapeutic advantage in human triple-negative breast cancer treatment. Copyright 2018, Spandidos Publications. All rights reserved.
    Sponsors
    This work was supported by Regional Operative Programme (ROP) Calabria ESF 2007/2013-IV Axis Human Capital-Operative Objective M2-Action d.5 Postdoctoral Fellowship, in collaboration with University of Calabria (Cs), Italy to M.P.. Thanks to this, M.P. was able to work in Kane's Lab and to collaborate with Dr Fletcher at University of Maryland, School of Pharmacy.
    Keyword
    Autophagy
    MDA-MB-231 breast cancer cells, Bcl-xL/Mcl-1 inhibitor
    RARγ antagonist
    Retinoids
    Identifier to cite or link to this item
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044638957&doi=10.3892%2fol.2018.8258&partnerID=40&md5=66e1ae13d1b6a4efec2eebc22338c15c; http://hdl.handle.net/10713/9081
    ae974a485f413a2113503eed53cd6c53
    10.3892/ol.2018.8258
    Scopus Count
    Collections
    UMB Open Access Articles 2018

    entitlement

     
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.